Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Hatfield Jeffrey S., Director. Director active across 2 companies, notably Vir Biotechnology, Inc.. Aggregated, 6 reports have been logged. History available since 21 May 2021. The latest transaction was disclosed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Jeffrey S. Hatfield is a Director at Vir Biotechnology, Inc. As a board member, he participates in overseeing operations and strategic decision-making. His experience is valuable in guiding the company's direction.